Please login to the form below

Not currently logged in
Email:
Password:

Organogenesis

This page shows the latest Organogenesis news and features for those working in and with pharma, biotech and healthcare.

Shire pays record $350m to settle US kickback allegations

Shire pays record $350m to settle US kickback allegations

Dermagraft has proved to be something of an expensive debacle for Shire, which took a $650m charge when it offloaded the product to Organogenesis, a decision prompted by its failure to

Latest news

  • Shire faces $650m loss on Dermagraft sale Shire faces $650m loss on Dermagraft sale

    Shire faces $650m loss on Dermagraft sale. Sells struggling foot ulcer treatment to Organogenesis. ... Organogenesis now owns the rights to all Dermagraft assets, including patents, product inventory and certain manufacturing equipment.

  • Improving the prospects for ATMPs in Europe

    Established products include Shire subsidiary Advanced Biohealing's Dermagraft, which is already generating sales of around $200m a year, and Novartis/Organogenesis' Apligraf, both of which are based on allogeneic cells

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch table for January 2014 Deal Watch table for January 2014

    320. Shire/ Organogenesis. Divestment. Shire's sale of its Dermagraft assets acquired as part of Advanced BioHealing.

  • Pharma deals during January 2014 Pharma deals during January 2014

    The Merck &Co divestment of Sirna is noted above but, this month, Shire announced the divestment of Dermagraft (a bioengineered skin substitution product for diabetic foot ulcers) to Organogenesis.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Vifor Pharma appoints Dario Eklund Vifor Pharma appoints Dario Eklund

    Eklund joins from Organogenesis, a regenerative medicine company which focuses in wound healing and soft tissue regeneration, where he was VP with responsibility for non-US operations, business development and licensing

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics